AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Merck & Co. Inc. (MRK)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

87.13

-0.15 (-0.17%)

At close: Feb 10, 2025, 10:31 AM

undefined% (undefined)

Bid	87.11
Market Cap	220.39B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	6.74
PE Ratio (ttm)	12.93
Forward PE	n/a
Analyst	Buy

Ask	87.14
Volume	2,938,704
Avg. Volume (20D)	12,877,548
Open	87.20
Previous Close	87.28
Day's Range	86.96 - 88.60
52-Week Range	86.96 - 134.63
Beta	undefined

About MRK

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops...

[Show more]

Industry Drug Manufacturers - General

Sector Healthcare

IPO Date Jan 13, 1978

Employees 70,000

Stock Exchange NYSE

Ticker Symbol MRK

Website https://www.merck.com

Analyst Forecast

According to 14 analyst ratings, the average rating for MRK stock is "Buy." The 12-month stock price forecast is $115, which is an increase of 31.99% from the latest price.

Buy 57.14%

Hold 28.57%

Sell 7.14%

Stock Forecasts

Next Earnings Release

Merck & Co. Inc. is scheduled to release its earnings on Apr 24, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

5 days ago

-9.07%

Merck shares are trading lower after the company i... Unlock content with Pro Subscription

2 weeks ago

+2.5%

Merck shares are trading higher after the company announced WELIREG has gained FDA priority review.

News

2 days ago · seekingalpha.com

One 'Safer' Buy In 10 February Dogs Of The Dow

Verizon is the only Dow Dog meeting the ideal of dividends from $1K invested exceeding single share price, supported by adequate free cash flow. Analysts project net gains of 15.23% to 33.94% for the ...

2 days ago · 247wallst.com

Wall Street Analysts Thought Merck Stock Had 10% Downside Risk Heading Into Earnings. That Materialized, So What's Next?

Merck & Co . (NYSE:MRK) is a prominent American multinational pharmaceutical company many investors know for its brand-name drugs such as Keytruda, and the myriad of commercials the company shows on p...

3 days ago · accessnewswire.com

Merck & Co., Inc. (MRK) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights

NEW YORK, NY / ACCESS Newswire / February 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Merck & Co., Inc. ("Merck & Co.") (NYSE:MRK) concerning possible viola...

4 days ago · accessnewswire.com

Investors who lost money on Merck & Co., Inc. should contact Levi & Korsinsky about an ongoing investigation - MRK

NEW YORK, NY / ACCESS Newswire / February 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Merck & Co., Inc. ("Merck & Co.") (NYSE:MRK) concerning possible viola...

3 days ago · businesswire.com

Merck Announces Phase 3 waveLINE-010 Trial Initiation Evaluating Zilovertamab Vedotin, an Investigational Antibody-Drug Conjugate, for the Treatment of Patients With Previously Untreated Diffuse Large B-Cell Lymphoma

RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of waveLINE-010, a pivotal Phase 3 clinical trial e...

4 days ago · seekingalpha.com

Merck: Don't Fight The Tape, How Low Can It Go?

Despite Merck & Co., Inc.'s strong fundamentals and promising pipeline, current negative sentiment suggests avoiding the stock until it stabilizes and shows signs of recovery. Merck's stock is underva...

5 days ago · zacks.com

Why Merck (MRK) is a Top Dividend Stock for Your Portfolio

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Merck (MRK) have what it takes?

5 days ago · forbes.com

Should You Pick MRK Stock At $90?

Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates. The company reported revenue of $15.6 billion and adjusted earnings of $1.72 per share, c...

5 days ago · youtube.com

Final Trade: SNAP, PYPL, SPYV, MRK

The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.

6 days ago · accessnewswire.com

Merck & Co., Inc. (MRK) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates

NEW YORK, NY / ACCESS Newswire / February 4, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Merck & Co., Inc. ("Merck & Co.") (NYSE:MRK) concerning possible viola...

Load More News